Blau Farmaceutica S.A.
- Address
- Rodovia Raposo Tavares Km 30 5, Jardim Dinorah
Sponsor Overview
Specializations
Haematology and anaemia
Blau Farmaceutica S.A. supports clinical research centred on symptomatic anaemia, with particular attention to anaemia linked to chronic renal failure and chronic kidney disease. The sponsor’s activity in this area reflects an interest in treatments that address reduced red blood cell production and the clinical consequences of persistent anaemia.
- Symptomatic anaemia
- Chronic renal failure
- Chronic kidney disease
- Red blood cell production
The research profile in this field is closely aligned with therapies used to manage anaemia in patients with impaired kidney function.
Erythropoiesis-stimulating therapy
The sponsor’s trials include work involving epoetin alfa, indicating a therapeutic focus on agents that stimulate erythropoiesis and support haemoglobin restoration. This places the company within the clinical development space for biologic treatments used to correct anaemia-related blood abnormalities.
- Epoetin alfa
- Erythropoiesis
- Haemoglobin
- Biologic therapy
Its research interest extends to the evaluation of blood-level behaviour and safety considerations for erythropoiesis-stimulating agents.
Clinical pharmacology and bioequivalence
Blau Farmaceutica S.A. is engaged in clinical research comparing blood levels of epoetin alfa products, reflecting a strong interest in pharmacokinetics and comparative drug performance. This area is relevant to the assessment of how closely a developed product matches an established reference therapy.
- Pharmacokinetics
- Blood levels
- Comparative product assessment
- Bioequivalence
The sponsor’s research activity in this domain supports the clinical evaluation of therapeutic consistency for epoetin alfa formulations.
Safety and tolerability assessment
The funded studies also focus on safety, tolerability, and effects on selected blood values in healthy volunteers and healthy male participants. This indicates interest in the early clinical characterisation of treatment-related effects on the blood system.
- Safety
- Tolerability
- Healthy volunteers
- Blood values
These investigations contribute to the understanding of how epoetin alfa is handled in the body and its impact on haematological markers.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Comparative Study of the Pharmacokinetics, Safety, and Tolerability of Epoetin Alfa Following Multiple Intravenous Doses in Healthy Male Participants |  Germany | Not Yet Recruiting |
| A Comparative Study of the Pharmacokinetics, Safety, and Tolerability of Single Intravenous Doses of Epoetin Alfa and Erythropoietin in Healthy Volunteers | Germany | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Hemic and Lymphatic Diseases2 trials249 other sponsors
Partnered Research Centres
1 centre- Address
- Wegenerstrasse 13, Ludwigsfeld, 89231 Neu-Ulm
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Blau Farmaceutica S.A..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.